LBO-06-Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients

Journal article

Peer reviewed

Xiaoli Ma, Jacob Lalezari, Tuan Nguyen, Ho Bae, Eugene R. Schiff, Scott Fung, Man-Fung Yuen, Tarek Hassanein, Hie-Won Hann, Magdy Elkhashab, …

Journal of hepatology, Vol.70(1), pp.e130-e130

Apr 2019

Additional Links

9 Record Views

Title: LBO-06-Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients
Creators: Xiaoli Ma
Jacob Lalezari
Tuan Nguyen
Ho Bae
Eugene R. Schiff
Scott Fung
Man-Fung Yuen
Tarek Hassanein
Hie-Won Hann
Magdy Elkhashab
Douglas Dieterich
Mark Sulkowski
Paul Kwo
Ronald Nahass
Kosh Agarwal
Alnoor Ramji
James Park
Natarajan Ravendhran
Sing Chan
Frank Weilert
Steven-Huy Han
Walid Ayoub
Edward Gane
Ira Jacobson
Michael Bennett
Qi Huang
Ran Yan
Vivian Huey
Eric Ruby
Sandy Liaw
Richard Colonno
Uri Lopatin
Publication Details: Journal of hepatology, Vol.70(1), pp.e130-e130
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Medicine (Graduate)
Identifiers: 991019167534004721

This output has contributed to the advancement of the following goals:

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output